/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

M

Matthias Klinger

Amgen (Germany)(DE)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

49

Papers

4.5K

Citations

18

h-index

21

i10-index

Matthias Klinger is an academic researcher from Amgen (Germany). The author has contributed to research in topics: Acute Lymphoblastic Leukemia research & CAR-T cell therapy research & Chronic Myeloid Leukemia Treatments. The author has an h-index of 18, co-authored 42 publications.

ORCID: 0000-0001-7468-1951

Research Topics

Acute Lymphoblastic Leukemia research CAR-T cell therapy research Chronic Myeloid Leukemia Treatments Monoclonal and Polyclonal Antibodies Research Lymphoma Diagnosis and Treatment

Papers by this author

works

Harnessing T cells to fight cancer with BiTE<sup>®</sup> antibody constructs – past developments and future directions

2016 · Immunological Reviews · 154 citations

https://doi.org/10.1111/imr.12393

Matthias Klinger Jonathan Benjamin Roman Kischel Sabine Stienen

Changes in clinical laboratory parameters and pharmacodynamic markers in response to blinatumomab treatment of patients with relapsed/refractory ALL

2017 · Experimental Hematology and Oncology · 71 citations

https://doi.org/10.1186/s40164-017-0074-5

Virginie Nägele Andrea Kratzer Gerhard Zugmaier Chris Holland

Research topics

topics

Acute Lymphoblastic Leukemia research

CAR-T cell therapy research

Chronic Myeloid Leukemia Treatments

Monoclonal and Polyclonal Antibodies Research

Lymphoma Diagnosis and Treatment

Chat about Author

Papers

Chat

Click to start Chat